#hot #news
Leading Pharma Acquires Conflux, Stock Soars 240%
Leading Pharmaceutical Biotech's acquisition of Conflux Blockchain assets sent its stock soaring nearly 240% on July 2 in Hong Kong.
This acquisition aims to blend biotech with blockchain, fueling speculation and market interest, despite a lack of formal announcements.